EC approves Henlius & Organon’s Bildyos and Bilprevda, biosimilars to Prolia and Xgeva respectively: Shanghai, China Monday, September 22, 2025, 14:00 Hrs [IST] Shanghai Henlius ...
NPPA releases draft calculation sheet with ceiling price of six scheduled formulations: Gireesh Babu, New Delhi Monday, ...
AusperBio completes enrollment in two phase II trials of AHB-137 for chronic hepatitis B: San Francisco Monday, September 22, 2025, 13:00 Hrs [IST] AusperBio Therapeutics, Inc. an ...
Celltrion announces commercial availability of Omlyclo across Europe at EADV 2025: Incheon, South Korea Monday, September 22, 2025, 12:00 Hrs [IST] Celltrion, Inc., a leading biop ...
Otsuka receive CRL from US FDA for sNDA of Rexulti in combination with sertraline to treat adults with post-traumatic stress disorder: Japan Monday, September 22, 2025, 10:00 Hrs ...
MAHE Centre for cGMP sets the tone for 3rd National cGMP Day on Oct 10 where revised Schedule M compliance takes centre stage: Our Bureau, Bengaluru Monday, September 22, 2025, 09 ...
DGTR reschedules hearing in anti-dumping probe on EDA imports from China, EU, Saudi Arabia & Taiwan: Shardul Nautiyal, Mumbai Monday, September 22, 2025, 08:00 Hrs [IST] The Direc ...
New B. Pharm syllabus will create globally competitive professionals: experts: Nandita Vijayasimha, Bengaluru Monday, September 22, 2025, 08:00 Hrs [IST] In a bold move to align p ...
Digital diagnostics shaping new standards in global treatment protocols: Expert: Nandita Vijayasimha, Bengaluru Monday, September 22, 2025, 08:00 Hrs [IST] The healthcare industry ...
Pharma MSMEs warn of nationwide protest against difficult regulatory environment: Peethaambaran Kunnathoor, Chennai Monday, September 22, 2025, 08:00 Hrs [IST] In a move highlight ...
NABH launches MITRA Empanelment Programme to support HCOs for accreditation: Shardul Nautiyal, Mumbai Saturday, September 20, ...
NIPER-Hyderabad and IDMA keen on industry academia partnerships: Our Bureau, Bengaluru Friday, September 19, 2025, 17:15 Hrs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results